Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CYRX vs CIIT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CYRX Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

CYRX Overall Winner 6-Pillar Tally: CYRX 5 – 1 CIIT Matrix Metrics: CYRX 9 – 1 CIIT

As of Nov 20, 2026, CryoPort, Inc. (CYRX) is the stronger overall head-to-head candidate over Tianci International, Inc. (CIIT) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CYRX carries a Unified Composite Score of 52.0/100 (HOLD) at $19.05 (77.5x Forward P/E, -14.4% operating margin), whereas CIIT carries 47.9/100 (HOLD) at $1.32 (N/M Forward P/E, -17.2% operating margin).

  • Technical & Structure Timing Caution: CYRX trades in a Markup technical trend (BREAKOUT options phase, RSI 52.9); meanwhile CIIT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CYRX vs CIIT
CYRX NASDAQ Head-to-Head Winner
CryoPort, Inc. Common Stock
Pharmaceutical Preparations
$19.05
-2.56% 1D
Market Cap $990.2M
TTM Revenue $192M
Forward P/E 77.5x
Beta / 30D Vol 1.53β · 81% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 39.0 Fund 52.0 Flow 70.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.8% over 20 days), RSI 53
RSI-14: 52.9 · SMA20: $18.75 · SMA50: $17.85
CIIT NASDAQ
Tianci International, Inc. Common Stock
Computer Communications Equipment
$1.32
-8.97% 1D
Market Cap $1.7M
TTM Revenue $14M
Forward P/E N/M
Beta / 30D Vol -7.63β · 226% Vol
Unified Composite Score
47.9 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -20.2%), weak momentum, RSI 35
RSI-14: 35.1 · SMA20: $1.80 · SMA50: $2.14

6-Pillar Scorecard Institutional Category Breakdown (CYRX 5 – 1 CIIT)

Columns: Metric · CYRX · CIIT
1. Valuation Multiples CYRX
Forward P/E 77.5x N/M
Trailing P/E 77.5x N/M
PEG Ratio N/M N/M
EV / Revenue 4.9x 0.1x
2. Growth & Scale CYRX
Revenue Growth (YoY) +13.5% -2.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $192M $14M
Market Cap $990.2M $1.7M
3. Profitability & Quality CYRX
Gross Margin 46.9% 7.4%
Operating Margin -14.4% -17.2%
Net Profit Margin -21.5% -16.7%
Return on Equity (ROE) -7.4% -57.4%
4. Balance Sheet & Cash Flow CIIT
Cash Generation (TTM) -$20M -$3.5M
Cash Flow Margin -10.3% -24.8%
Net Cash / Leverage $48M Net Cash -$646,303 Net Debt (0.03x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CYRX
Options Structure Phase BREAKOUT UNCLASSIFIED
Current IV / %ile 62.6% (9th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase DISTRIBUTION · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CYRX
OpEx & R&D Intensity 61.3% of Rev ($118M) 24.6% of Rev ($3.5M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Integrated Freight & Logistics Operator Integrated Freight & Logistics Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CYRX (9) vs CIIT (1)
Institutional Metric CYRX CIIT Criterion Row Edge
Market Capitalization
Scale
$990.2M $1.7M Larger Scale CYRX
Trailing P/E Ratio
Valuation
77.5x N/M Lower Multiple CYRX
Forward P/E Ratio
Valuation
77.5x N/M Lower Multiple CYRX
Revenue Growth (YoY)
Growth
+13.5% -2.0% Higher Growth CYRX
Operating Margin (TTM)
Profitability
-14.4% -17.2% Higher Margin CYRX
Net Profit Margin
Profitability
-21.5% -16.7% Higher Margin CIIT
Return on Equity (ROE)
Capital Efficiency
-7.4% -57.4% Higher ROE CYRX
52-Week Range Position
Momentum
81% ($8–$22) 25% ($0–$5) Stronger Trend CYRX
Beta / 30D Volatility
Risk Regime
1.53β · 81% Vol -7.63β · 226% Vol Lower Realized Risk CYRX
Unified Institutional Score
Composite Signal
52.0 / 100 (HOLD) 47.9 / 100 (HOLD) Higher Composite CYRX
Trailing 12M Revenue (USD)
Operating Scale
$192M $14M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
46.9% 7.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.9x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$20M ($48M Net Cash) -$3.5M (-$646,303 Net Debt (0.03x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CYRX +39.49 pp
CYRX: +6.84% · CIIT: -32.65%
3M Horizon CYRX +77.42 pp
CYRX: +16.59% · CIIT: -60.83%
6M Horizon CYRX +36.82 pp
CYRX: +36.07% · CIIT: -0.75%
1Y Horizon CIIT +74.07 pp
CYRX: +125.18% · CIIT: +199.25%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CYRX Revenue CIIT Revenue CYRX Op. Margin CIIT Op. Margin Margin Leader
FY2019 $30M N/A -52.1% N/A CYRX
FY2020 $80M N/A -38.1% N/A CYRX
FY2021 $220M N/A -8.0% N/A CYRX
FY2022 $240M $0M -13.4% 25.5% CIIT
FY2023 $170M $0M -59.6% -76.0% CYRX
FY2024 $160M $10M -77.6% 2.0% CIIT
FY2025 $180M $10M -20.9% -29.2% CYRX
FY2026 N/A $10M N/A -17.2% CIIT

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CYRX BREAKOUT
119d in phase · OBV DISTRIBUTION
Current IV 62.6%
IV Percentile 9th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact CYRX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CIIT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CIIT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CYRX Moat Profile Cyclical / Execution-Driven Positioning
Integrated Freight & Logistics Operator
Competes within the Integrated Freight & Logistics value chain with $990.2M market capitalization and -14.4% operating margin.
OpEx & R&D Reinvestment 61.3% of Rev ($118M)
90D Engineering Disclosures 0 Published
CIIT Moat Profile Cyclical / Execution-Driven Positioning
Integrated Freight & Logistics Operator
Competes within the Integrated Freight & Logistics value chain with $1.7M market capitalization and -17.2% operating margin.
OpEx & R&D Reinvestment 24.6% of Rev ($3.5M)
90D Engineering Disclosures 0 Published

Investor FAQ CYRX vs CIIT Key Questions & Quantitative Answers

As of Nov 20, 2026, CryoPort, Inc. (CYRX) is the stronger overall head-to-head candidate over Tianci International, Inc. (CIIT) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CYRX carries a Unified Composite Score of 52.0/100 (HOLD) at $19.05 (77.5x Forward P/E, -14.4% operating margin), whereas CIIT carries 47.9/100 (HOLD) at $1.32 (N/M Forward P/E, -17.2% operating margin). Technical & Structure Timing Caution: CYRX trades in a Markup technical trend (BREAKOUT options phase, RSI 52.9); meanwhile CIIT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CYRX leads the Growth & Scale pillar: CYRX posts +13.5% YoY revenue growth and +0.0% YoY earnings growth on $192M TTM revenue (46.9% gross margin, -14.4% operating margin), compared with CIIT at -2.0% YoY revenue growth and +0.0% YoY earnings growth on $14M TTM revenue (7.4% gross margin, -17.2% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), CYRX cumulative revenue shifted +500.0% while CIIT shifted +0.0%. In operating R&D and SG&A reinvestment, CYRX deploys 61.3% of Rev ($118M) (0 90-day corporate R&D disclosures) versus 24.6% of Rev ($3.5M) (0 disclosures) for CIIT.

CYRX screens cheaper on headline valuation multiples. CYRX trades at 77.5x Forward P/E, 77.5x Trailing P/E, N/M PEG, and 4.9x EV/Revenue (-10.3% FCF margin), whereas CIIT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-24.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CYRX (-7.4% ROE) versus CIIT (-57.4% ROE) capital efficiency.

In options market volatility and institutional positioning, CYRX carries 62.6% implied volatility (9th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKOUT options structure phase (1.53β · 81% Vol realized risk). By comparison, CIIT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-7.63β · 226% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.